July 23, 2025 Bulletins ADJUSTMENT OF PRESUMPTIVELY ACCEPTABLE CREDIT LIFEINSURANCE AND CREDIT ACCIDENT AND HEALTH INSURANCE PREMIUM RATES Updated Bulletin 2025-002 THIS UPDATED BULLETIN IS ISSUED this 23rd day of July, 2025. THE FOLLOWING BULLETIN is updated and issued pursuant to NMSA 1978, Sections 59A-2-8 and 59A-2-10 and 13.1.2 NMAC, 13.18.2.18, and 13.18.2.26 NMAC.This update is being issued to allow a sixty-day (60-day) time period from the date of the effective date of July 1, 2025 for implementation of the new rates. The new rates shall be implemented on or before September 1, 2025. Please note: Additional filing instructions appear on page 6. 13.18.2.18 and 13.18.2.26 NMAC allows the Superintendent to set and adjust premium rates for Credit Life and Credit Accident and Health benefits as needed. Presumptively Acceptable Credit Life Insurance Premiums (prima facie): The Superintendent may presume that the benefits of a credit life insurance policy are reasonable in relation to the premium charged if the premium rate for death benefits as filed does not exceed an amount equal, or actuarially equivalent, to the following rates, which are the same prima facie rates that are currently in effect and that shall remain effective as of July 1, 2025:For complete bulletin content please see PDF below. ADJUSTMENT OF PRESUMPTIVELY ACCEPTABLE CREDIT LIFEINSURANCE AND CREDIT ACCIDENT AND HEALTH INSURANCE PREMIUM RATES
June 26, 2026 Bulletins MEDICAL MALPRACTICE PREMIUM REDUCTION AMENDED BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […] Read More
June 12, 2026 Announcements NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. […] Read More